Krystal Biotech to Present at Chardan Annual Genetic Medicines Conference
PITTSBURGH, Oct. 04, 2018 (GLOBE NEWSWIRE) -- Krystal Biotech Inc., (“Krystal”) (NASDAQ: KRYS), a gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from skin diseases, today announced that Krish S. …